Claims for Patent: 7,060,673
✉ Email this page to a colleague
Summary for Patent: 7,060,673
Title: | Fusion peptide of human parathyroid hormone derived peptide and tat peptide, preparation thereof, and skin slimming cosmetic composition comprising the same |
Abstract: | The present invention relates to a fusion peptide wherein a self cell-penetrating Tat peptide having a self penetrating signal is bound to a human parathyroid hormone-derived peptide, a preparation thereof, and a skin slimming cosmetic composition comprising the same. Since the fusion peptide wherein the Tat peptide is bound to the human parathyroid hormone-derived peptide has high stability and superior skin absorption, the present invention provides a skin slimming agent having superior lipolysis effects and improved durability of the effects. |
Inventor(s): | Song; Young-Sook (Taejeon, KR), Kang; Nae-Gyu (Taejeon, KR), Park; Sun-Gyoo (Taejeon, KR), Cho; Wan-Goo (Taejeon, KR), Lee; Yong-Hwa (Taejeon, KR), Lim; Jun-Man (Taejeon, KR), Min; Hye-Jung (Taejeon, KR), Chang; Min-Youl (Taejeon, KR), Kang; Seh-Hoon (Taejeon, KR) |
Assignee: | LG Household and Health Care Ltd. (Seoul, KR) |
Application Number: | 10/296,033 |
Patent Claims: | 1. A fusion peptide of Tat-hPTHDP, wherein C-terminal amino acid residue of a self cell-penetrating Tat peptide of HIV Type-1 is bound to N-terminal amino acid residue of
human parathyroid hormone-derived peptide (hPTHDP), wherein Tat peptide is selected from the group consisting of amino acid sequences of SEQ ID NOs. 7, 8 and 9, and wherein hPTHDP is selected from the group consisting of amino acid sequences of SEQ ID
NOs:1, 2, 3, 4, 5 and 6.
2. A skin slimnniing cosmctic composition comprising the fusion peptide of claim 1 as an active ingredient. 3. The skin slimming cosmetic composition according to claim 2, wherein the fusion peptide of claim 1 is contained in an amount of 0.000001 to 5.0 wt %. |
Details for Patent 7,060,673
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Nps Pharmaceuticals, Inc. | NATPARA | parathyroid hormone | For Injection | 125511 | 01/23/2015 | ⤷ Try a Trial | 2021-09-27 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.